Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Polyethylene glycol** is a family of inert, water-soluble polyether polymers whose clinical properties depend substantially on molecular weight and formulation. High-molecular-weight oral preparations, particularly polyethylene glycol 3350, act as **osmotic laxatives**: they remain largely unabsorbed in the gastrointestinal tract and retain water in the bowel lumen, softening stool and promoting bowel movements. Polyethylene glycol is also used in bowel-cleansing preparations, typically with electrolytes, and can serve as a lubricant or vehicle in ophthalmic formulations. The unqualified term is not chemically specific because it can refer to PEG materials with different average molecular weights and clinical uses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol.